# Open-label, Flexible-dose Study of Vortioxetine in Patients With Depression in India

> **NCT04288895** · PHASE4 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 400 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Vortioxetine

## Key facts

- **NCT ID:** NCT04288895
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-20
- **Primary completion:** 2022-02-11
- **Final completion:** 2022-03-12
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2022-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04288895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04288895, "Open-label, Flexible-dose Study of Vortioxetine in Patients With Depression in India". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04288895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*